Antenatal Steroids Before Early Cesarean Linked to Dramatic Drop in NICU Admissions: Study

Could a simple intervention before elective cesarean delivery make a life-changing difference for newborns? Neonates delivered by elective cesarean section before 39 weeks face a heightened risk of respiratory distress and intensive care admission. Recent audit data shed light on the real-world impact of prophylactic corticosteroids in this common clinical scenario.

Study Design: Real-World Evidence From a Retrospective Audit

This clinical audit, conducted at a UAE tertiary care center, analyzed 60 singleton pregnancies delivered via elective cesarean between 37 and 38+6 weeks gestation. Most women (90%) received either betamethasone or dexamethasone before surgery, following current recommendations for lung maturation. The research compared neonatal respiratory outcomes and NICU admissions between those who did and did not receive corticosteroids.

Key Findings: Marked Reduction in Neonatal Respiratory Complications

The results were compelling:

11.6% of all infants required NICU admission for respiratory issues.

Among infants whose mothers received corticosteroids, only 2 out of 54 (3.7%) needed NICU care.

In contrast, 5 out of 6 (83%) of those without steroid exposure were admitted to the NICU.

Both transient tachypnea of the newborn (TTN) and respiratory distress syndrome (RDS) were significantly more common in infants not exposed to antenatal steroids.

No Significant Difference Between Steroid Types

The audit found no significant difference in effectiveness between betamethasone and dexamethasone. Both regimens were associated with improved neonatal outcomes and fewer respiratory complications when given in the recommended timeframe (within 24 hours to 7 days before delivery).

Clinical Implications: Should Steroids Be Routine Before Early Cesarean?

For clinicians, these findings underscore the value of prophylactic corticosteroids when elective cesarean cannot be postponed until 39 weeks. The intervention is straightforward, evidence-based, and—according to this and prior studies—does not appear to favor one steroid type over another.

However, caution is warranted in certain populations, such as those with diabetes or systemic infection. Close monitoring is essential due to possible metabolic side effects of steroids in these high-risk groups.

The Broader Context: Ongoing Questions and Future Research

While the short-term benefits for respiratory outcomes are clear, lingering questions remain about possible long-term neurodevelopmental or metabolic risks, especially with repeated or unnecessary courses. Large-scale, randomized studies are needed to further clarify optimal dosing, timing, and safety beyond the neonatal period.

Conclusion

Prophylactic antenatal corticosteroids, given before elective cesarean section prior to 39 weeks, can substantially reduce the risk of neonatal respiratory morbidity and NICU admission. Both betamethasone and dexamethasone are effective, supporting their routine use in eligible women when early delivery is unavoidable. As always, individual patient factors and ongoing research should guide clinical decisions.

Key Points

Prophylactic corticosteroids before elective cesarean <39 weeks lower neonatal respiratory complications.

NICU admissions for respiratory issues were dramatically reduced with steroid use.

No clinically significant differences were observed between dexamethasone and betamethasone.

High-risk groups (e.g., diabetes, infection) may require closer monitoring if steroids are used.

Long-term safety and best practices for steroid administration still need clarification through further research.

Citation:

Ambreen N, Arif S, Javeria K. Administration of Prophylactic Corticosteroids in Women Delivered by Elective Cesarean Section Before 39 Weeks of Gestation. Gynecol Obstet Open Acc. 2026;9:270. DOI: https://doi.org/10.29011/2577-2236.100270